EFFECT OF TREATMENT WITH PENTOXIFYLLINE ABOUT THE RISK RATER OF POST-angioplasty restenosis IN PATIENTS WITH LOWER LIMB arterial disease [EFFETTO DEL TRATTAMENTO CON PENTOSSIFILLINA SUL RISCHIO DI RESTENOSI POST-ANGIOPLASTICA IN PAZIENTI AFFETTI DA ARTERIOPATIA OBLITERANTE DEGLI ARTI INFERIORI]

Trial Profile

EFFECT OF TREATMENT WITH PENTOXIFYLLINE ABOUT THE RISK RATER OF POST-angioplasty restenosis IN PATIENTS WITH LOWER LIMB arterial disease [EFFETTO DEL TRATTAMENTO CON PENTOSSIFILLINA SUL RISCHIO DI RESTENOSI POST-ANGIOPLASTICA IN PAZIENTI AFFETTI DA ARTERIOPATIA OBLITERANTE DEGLI ARTI INFERIORI]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Mar 2014

At a glance

  • Drugs Pentoxifylline (Primary)
  • Indications Peripheral arterial disorders; Restenosis
  • Focus Therapeutic Use
  • Acronyms PENT-PTA
  • Most Recent Events

    • 10 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top